DekaBank Deutsche Girozentrale - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,091
+2.6%
42,617
+6.5%
0.00%
+50.0%
Q2 2023$1,063
-99.7%
40,000
+53.3%
0.00%
+100.0%
Q2 2022$402,000
-44.1%
26,1000.0%0.00%
-50.0%
Q1 2022$719,000
-21.8%
26,100
+10.1%
0.00%0.0%
Q4 2021$920,000
-14.8%
23,700
+2.6%
0.00%
-33.3%
Q3 2021$1,080,000
+285.7%
23,100
+185.2%
0.00%
+200.0%
Q2 2021$280,000
-10.8%
8,1000.0%0.00%0.0%
Q1 2021$314,000
-8.5%
8,1000.0%0.00%0.0%
Q4 2020$343,0008,1000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders